Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$245,225
-$355,740 QoQ
Shares Held
1,941
-72.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,796
of 2,266 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Optiver Holding B.V. holds $26,373,774 across 11 Drug Manufacturers - General names. GILD ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
90,150 | $17,094,243 | |
| 2 | SNY |
Sanofi
|
115,761 | $4,938,364 | |
| 3 | NVO |
Novo Nordisk A S
|
47,719 | $2,287,648 | |
| 4 | GSK |
GSK plc
|
15,941 | $835,627 | |
| 5 | AMGN |
Amgen Inc
|
1,448 | $524,349 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,941 | $245,225 | |
| 7 | PFE |
Pfizer Inc
|
7,242 | $174,387 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,302 | $132,641 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,225 | 1,941 | Shares | Defined | 2026-08-12 | |
| 2024-09-30 | $600,965 | 7,168 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $2,025 | 25 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $374 | 5 | Shares | Defined | 2023-11-13 | |
| 2022-03-31 | $4,042 | 68 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,666 | 202 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,826 | 155 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,550 | 342 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||